Product Images 2% Lidocaine Hci

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with 2% Lidocaine Hci NDC 51662-1326 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Serialized Pouch Label - 5166213262 label

Serialized Pouch Label - 5166213262 label

This is a description of a 50mL vial of 2% Lidocaine HCI Injection, USP with a strength of 1000mg/50mL (20mg/mL) and lot number ABCDEFGHIJKLMNOPQRST, with an expiration date of 2021-06-01. The product is intended for infiltration and nerve block, but not for epidural and caudal use, and contains a preservative. It should only be used if the seal is intact and undamaged, with aseptic technique employed. The product should be stored between 20 to 25C (68 to 77F). The manufacturer's package insert should be consulted. The product is distributed by HF Acquisition Co., LLC based in Mukilteo, WA 98275.*

Serialized RFID Label - 5166213263 RFID label

Serialized RFID Label - 5166213263 RFID label

This appears to be a product identification code containing a serial number ("SN s") and various other codes and numbers, including a GTIN-14 barcode ("(01) 00351662132630"), a batch or lot number ("(17) 210601"), and a product code ("(10) ABC123"). The text also mentions a manufacturer's package insert and a distribution company located in Mukilteo, Washington.*

Serialized Case Label - 5166213263 label

Serialized Case Label - 5166213263 label

2% lidocaine HCI injection is a medication used for infiltration and nerve block; not for epidural and caudal use, and it contains a preservative. It comes in a 50mL vial with a concentration of 20mg/mL and a box of 25. The lot number is ABCDEFGHIJKLMNOPQRST, with an expiration date of 2021-06-01. It is recommended to use aseptic technique when handling the injection and to only use it if the seal is intact and undamaged. The injection should be stored at 20-25°C (68-77°F). More information on how to use this medication is available in the manufacturer's package insert, and it is distributed by HF Acquisition Co., LLC located in Mukilteo, WA.*

DESCRIPTION - DESCRIPTION TABLE 1

DESCRIPTION - DESCRIPTION TABLE 1

This is a description of the concentration of lidocaine HCI and sodium chloride, expressed in milligrams per milliliter (mg/mL). The concentration is 10 mg/mL for lidocaine HCI (anhyd.) and the concentration of sodium chloride is not specified.*

1 - DOSAGE 1

1 - DOSAGE 1

This is a description of different types of single-dose containers with varying sizes and concentrations. There are 30 mL tear-top vials with a 1% concentration, 20 mL ampuls with a 150% concentration, and 10 mL ampuls with a 2% concentration.*

2 - DOSAGE 2

2 - DOSAGE 2

1 - HOW SUPPLIED 1

1 - HOW SUPPLIED 1

This is a list of medication products with their corresponding National Drug Codes (NDC). The products come in different doses, presentation types, and packaging (i.e., Carton, Case, Tray). The medication is in the form of glass ampuls, vials, or teartop vials that contain different concentrations of the medication (i.e., 0.50%, 1%, 1.50%, and 2%) which range from 5 to 20 mg/mL.*

2 - HOW SUPPLIED 2

2 - HOW SUPPLIED 2

This is a description of various medications presented in NDC codes and dosage strengths for a single-dose application. The medications are presented in clamshells and glass ampuls with varying mg/mL concentrations depending on the NDC code. There are different doses for the medication depending on whether the dose is 1% or 2%.*

3 - HOW SUPPLIED 3

3 - HOW SUPPLIED 3

This is the packaging and dosing information of multiple-dose vials with different concentrations of a drug, indicated by their NDC numbers. The vials are packed in trays of 25 and are available in different sizes, ranging from 200mg/20mL to 1000mg/50mL. The vials are made of plastic and have a flip-top lid. The concentration of the drug in each vial varies from 5mg/mL to 20mg/mL.*

LOGO - LOGO

LOGO - LOGO

Label 1 - Label 1 51662 1326 1 March 2021 Update

Label 1 - Label 1 51662 1326 1 March 2021 Update

This text appears to be a description of a medication administered through infiltration and nerve block. It comes in a 50mL container with a preservative but is not to be used for epidural and caudal applications. The solution contains Lidocaine HC| g, sodium chloride, and methylparaben, and can be adjusted with HCl and/or NaOH for pH. The solution is sterile, non-pyrogenic, and stored at controlled room temperature. The usual dosage is not specified. The text also includes manufacturer, distributor, and expiration information.*

Label 2 - Label 2 51662 1326 1 March 2021 Update

Label 2 - Label 2 51662 1326 1 March 2021 Update

This is a description of a 50mL injection of Lidocaine HCI 2%, distributed by Hospira Inc. for infiltration and nerve block, with a total of 1000mg of the medication in the 50mL solution, equivalent to a concentration of 20mg/mL. Each mL contains anhydrous lidocaine hydrochloride (HCl) at 20mg, as well as 6mg of sodium chloride and 1mg of methylparaben, which acts as a preservative. The solution may contain HCl and/or NaOH for pH adjustment, with a pH range of 5.0 to 7.0 (pH 6.5). The solution is sterile, non-pyrogenic and not for epidural or caudal use. The recommended dosage is specified by a medical professional, and the solution should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F).*

VIAL LABEL - Multidose Vial Label

VIAL LABEL - Multidose Vial Label

This is a description of Lidocaine HCI Injection, USP. It is a prescription drug used for infiltration and nerve block. Each 50mL bottle contains 1000mg of lidocaine. It is a sterile and non-pyrogenic solution that may contain HCl and/or NaOH for pH adjustment. The usual dosage is mentioned on the insert. The drug should be stored at 20 to 25°C (68 to 77 [see USP Controlled Room Temperature]). The manufacturer of the drug is Hospira, Inc. based in Lake Forest, IL 60045 USA.*

SERIALIZED LABEL - SERIALIZED 51662 1326 1

SERIALIZED LABEL - SERIALIZED 51662 1326 1

STRUCTURE - STRUCTURE

STRUCTURE - STRUCTURE

Serialized Label - Serialized Label 51662 1326 1 March 2021

Serialized Label - Serialized Label 51662 1326 1 March 2021

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.